Business

Pfizer to Ask Regulators to Authorize Covid-19 Vaccine Booster

Pfizer Inc. will seek clearance from U.S. regulators in coming weeks to distribute a booster shot of its Covid-19 vaccine to heighten protection against infections as new virus strains rise.

The company said also it plans to start clinical trials in August of an updated version of its vaccine that would better protect against the Delta variant.

Pfizer and partner BioNTech SE said Thursday that they will seek authorization for the third shot based on encouraging initial study data.

The data showed, the companies said, that a booster shot given at least six months after the second dose produced antibodies protective against the original strain of the virus and a more recent strain known as Beta.

The companies said the antibody levels were five to 10 times higher than after two doses.

You May Also Like

World

France, which has opened its borders to Canadian tourists, is eager to see Canada reopen to the French. The Canadian border remains closed...

Health

Kashechewan First Nation in northern Ontario is experiencing a “deepening state of emergency” as a result of surging COVID-19 cases in the community...

World

The virus that causes COVID-19 could have started spreading in China as early as October 2019, two months before the first case was identified in the central city of Wuhan, a new study...

World

April Ross and Alix Klineman won the first Olympic gold medal for the United States in women’s beach volleyball since 2012 on Friday,...

© 2021 Newslebrity.com - All Rights Reserved.